GlassScriptPhysician profile
Danelle Kay Chambers
NPI 1730281122
$2,233.13
in general payments reported to CMS, 2019-2025
23 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $78.73 · 2021: $204 · 2022: $168 · 2023: $184 · 2024: $103 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $990 · Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $990.00 |
| Food and Beverage | $447.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,055.00 | 2025 | |
| Covidien LP | $197.37 | 2019-2020 | |
| Allergan, INC. | $176.53 | 2021-2022 | |
| Bard Access Systems, INC. | $140.35 | 2019 | |
| Heron Therapeutics, INC. | $119.54 | 2021-2024 | Zynrelef, Aponvie |
| Innovation Technologies INC | $73.73 | 2023-2025 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $55.70 | 2022-2023 | Seglentis |
| Merit Medical Systems INC | $46.43 | 2023 | Savi Scout |
| Pacira Pharmaceuticals Incorporated | $37.15 | 2019-2020 | |
| Medtronic, INC. | $36.86 | 2022 | |
| W. L. Gore & Associates, INC. | $36.78 | 2024 | Gore Synecor Biomaterial |
| Smith+Nephew, INC. | $35.76 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $29.50 | 2022 | |
| Conmed Corporation | $26.31 | 2025 | Visiclear |
| Livanova USA, INC. | $26.16 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24.00 | 2022 | |
| Hologic Sales and Service, LLC | $20.71 | 2023 | Affirm Prone Biopsy System, Localizer, Biozorb |
| Solventum Corporation | $19.60 | 2025 | V.A.C.Ulta, Bair Hugger, Activ.A.C. |
| Focal Therapeutics, INC. | $19.22 | 2020 | |
| Leica Microsystems INC. | $15.67 | 2023 | Mammotome Elite |
| Angiodynamics, INC. | $14.25 | 2022 | |
| Ethicon US, LLC | $13.80 | 2023 | Vistaseal, Harmonic, Echelon Flex |
| Checkpoint Surgical, INC | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danelle Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.